跳转至内容
Merck

GF34949289

wire reel, 500m, diameter 0.5mm, as drawn, 99.95+%

别名:

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
Al
CAS号:
分子量:
26.98
MDL號碼:
分類程式碼代碼:
12141702
PubChem物質ID:
NACRES:
NA.23

化驗

99.95%

形狀

wire

自燃溫度

1400 °F

製造商/商標名

Goodfellow 349-492-89

電阻係數

2.6548 μΩ-cm

長度 × 直徑

500 m × 0.5 mm

bp

2460 °C (lit.)

mp

660.37 °C (lit.)

密度

2.7 g/mL at 25 °C (lit.)

SMILES 字串

[Al]

InChI

1S/Al

InChI 密鑰

XAGFODPZIPBFFR-UHFFFAOYSA-N

一般說明

For updated SDS information please visit www.goodfellow.com.

法律資訊

Product of Goodfellow

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ryan J Mailloux et al.
Experimental cell research, 317(16), 2231-2238 (2011-07-27)
Aluminum (Al) is a metal toxin that has been implicated in the etiology of a number of diseases including Alzheimer's, Parkinson's, dialysis encephalopathy, and osteomalacia. Al has been shown to exert its effects by disrupting lipid membrane fluidity, perturbing iron
Todd D Terhune et al.
Journal of immunotoxicology, 10(2), 210-222 (2012-09-13)
Aluminum-containing adjuvants increase the effectiveness of vaccination, but their ability to augment immune responsiveness also carries the risk of eliciting non-target responses, especially in genetically susceptible individuals. This study reviews the relevant actions of aluminum adjuvants and sources of genetic
J R Walton
Journal of Alzheimer's disease : JAD, 29(2), 255-273 (2012-02-15)
Most humans living in industrialized societies are routinely exposed to bioavailable aluminum salts in the form of additives-in commercially-prepared foods, alum-clarified drinking water, certain pharmaceuticals, sunscreens, and other topical applications. Minute amounts of this aluminum are absorbed into the circulation.
Simone Vecchi et al.
Journal of pharmaceutical sciences, 101(1), 17-20 (2011-09-16)
Aluminum (Al) salt-based adjuvants are present in a large variety of licensed vaccines and their use is widely considered for formulations in clinical trials. Although the regulatory agencies have clearly stated the acceptable levels of Al salts in vaccines for
Maire E Percy et al.
Journal of inorganic biochemistry, 105(11), 1505-1512 (2011-11-22)
In 1991, treatment with low dose intramuscular desferrioxamine (DFO), a trivalent chelator that can remove excessive iron and/or aluminum from the body, was reported to slow the progression of Alzheimer's disease (AD) by a factor of two. Twenty years later

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门